Eight Organizations Earn AAHRPP Accreditation
The Association for the Accreditation of Human Research Protection Programs (AAHRPP) is pleased to announce that eight new organizations have been awarded Full Accreditation at the most recent meeting of its Council on Accreditation. AAHRPP's accreditation program is the field's primary vehicle for setting uniform, high standards across the research enterprise—in both the private and non-profit sectors. Accreditation internationally recognizes individual HRPPs that have demonstrated their commitment to providing strong protections to research participants and is capable of delivering on that promise. The list of accredited organization now includes the following organizations:
- Central Arkansas Veterans Healthcare System, Little Rock, AR
- Children's National Medical Center, Washington, DC
- Guthrie Healthcare System, Sayre, PA
- Mayo Clinic, Rochester, MN
- Minneapolis Medical Research Foundation, Minneapolis, MN
- The Rockefeller University, New York, NY
- Wake Forest University Health Sciences, Winston-Salem, NC
- William Beaumont Hospital, Royal Oak, MI
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
